{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:50:24Z","timestamp":1791978624483,"version":"4.4.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Biotin-thiamine-responsive basal ganglia disease is a rare, autosomal recessive, treatable, neurometabolic disorder associated with biallelic pathogenic variations in the\n                      <jats:italic toggle=\"yes\">SLC19A3<\/jats:italic>\n                      gene. The condition may present as an early-childhood encephalopathy, an early-infantile lethal encephalopathy with lactic acidosis, with or without infantile spasms, or a late-onset Wernicke-like encephalopathy. The key radiological features are bilateral, symmetrical lesions in the caudate, putamen, and medial thalamus, with variable extension into the brain stem, cerebral cortex, and cerebellum. Treatment is life long and includes initiation of high dose biotin and thiamine. Genetic testing confirms the diagnosis. The prognosis depends on the time from diagnosis to the time of vitamin supplementation. The genotype-phenotype correlations are not clear yet, but the early infantile phenotype portends a poorer prognosis. We provide a brief overview of the disorder and emphasize the initiation of high-dose biotin and thiamine in infants and children with unexplained encephalopathy and basal ganglia involvement.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aian.aian_952_20","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:54:39Z","timestamp":1617152079000},"page":"173-177","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Biotin-Thiamine-Responsive Basal Ganglia Disease in Children"],"prefix":"10.4103","volume":"24","author":[{"given":"Arushi G.","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvasini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20240828","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jimd.12125","article-title":"Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies","volume":"42","author":"Marce-Grau","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"R2-12-20240828","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/brain\/121.7.1267","article-title":"Biotin-responsive basal ganglia disease: A novel entity","volume":"121","author":"Ozand","year":"1998","journal-title":"Brain"},{"key":"R3-12-20240828","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-8-83","article-title":"Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: A retrospective review of the clinical, radiological and molecular findings of 18 new cases","volume":"8","author":"Alfadhel","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R4-12-20240828","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/ajmg.a.38189","article-title":"Biotin-thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next-generation sequencing data","volume":"173","author":"Ferreira","year":"2017","journal-title":"Am J Med Genet A"},{"key":"R5-12-20240828","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/acn3.50898","article-title":"Targeted SLC19A3 gene sequencing of 3000 Saudi newborn: A pilot study toward newborn screening","volume":"6","author":"Alfadhel","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"R6-12-20240828","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1006\/mgme.2000.3112","article-title":"Identification and characterization of the human and mouse SLC19A3 gene: A novel member of the reduced folate family of micronutrient transporter genes","volume":"71","author":"Eudy","year":"2000","journal-title":"Mol Genet Metab"},{"key":"R7-12-20240828","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/10372","article-title":"Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness","volume":"22","author":"Labay","year":"1999","journal-title":"Nat Genet"},{"key":"R8-12-20240828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/431216","article-title":"Biotin-responsive basal ganglia disease maps to 2q36 and is due to mutations in SLC19A3","volume":"77","author":"Zeng","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R9-12-20240828","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0925-4439(01)00073-4","article-title":"SLC19A3 encodes a second thiamine transporter ThTr2","volume":"1537","author":"Rajgopal","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"R10-12-20240828","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/bpa.12117","article-title":"Stress-induced upregulation of SLC19A3 is impaired in biotin-thiamine-responsive basal ganglia disease","volume":"24","author":"Schanzer","year":"2014","journal-title":"Brain Pathol"},{"key":"R11-12-20240828","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1750-1172-9-92","article-title":"Thiamine transporter-2 deficiency: Outcome and treatment monitoring","volume":"9","author":"Ortigoza-Escobar","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"R12-12-20240828","doi-asserted-by":"crossref","first-page":"C851","DOI":"10.1152\/ajpcell.00105.2006","article-title":"Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: Biotin is not a substrate for hTHTR2","volume":"291","author":"Subramanian","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"R13-12-20240828","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/jhg.2015.35","article-title":"Biotin-responsive basal ganglia disease: A case diagnosed by whole exome sequencing","volume":"60","author":"Kohrogi","year":"2015","journal-title":"J Hum Genet"},{"key":"R14-12-20240828","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24998","article-title":"Thiamine deficiency in childhood with attention to genetic causes: Survival and outcome predictors","volume":"82","author":"Ortigoza-Escobar","year":"2017","journal-title":"Ann Neurol"},{"key":"R15-12-20240828","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/brain\/awt054","article-title":"Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy","volume":"136","author":"Kevelam","year":"2013","journal-title":"Brain"},{"key":"R16-12-20240828","doi-asserted-by":"crossref","first-page":"e1670","DOI":"10.1542\/peds.2012-2988","article-title":"Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency","volume":"131","author":"Perez-Duenas","year":"2013","journal-title":"Pediatrics"},{"key":"R17-12-20240828","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1471-2350-11-171","article-title":"A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations","volume":"11","author":"Yamada","year":"2010","journal-title":"BMC Med Genet"},{"key":"R18-12-20240828","first-page":"368","article-title":"Whole exome sequencing reveals compound heterozygous mutations in SLC19A3 causing biotin-thiamine responsive basal ganglia disease","volume":"1","author":"Sremba","year":"2014","journal-title":"Mol Genet Metab Rep"},{"key":"R19-12-20240828","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMc0809100","article-title":"Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy","volume":"360","author":"Kono","year":"2009","journal-title":"N Engl J Med"},{"key":"R20-12-20240828","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/brain\/awv342","article-title":"Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: A treatable cause of Leigh syndrome","volume":"139","author":"Ortigoza-Escobar","year":"2016","journal-title":"Brain"},{"key":"R21-12-20240828","doi-asserted-by":"crossref","first-page":"2329048X18773218","DOI":"10.1177\/2329048X18773218","article-title":"Biotin-thiamine-responsive basal ganglia disease: Case report and follow-up of a patient with poor compliance","volume":"5","author":"Alabdulqader","year":"2018","journal-title":"Child Neurol Open"},{"key":"R22-12-20240828","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0b013e31827deb4c","article-title":"Biotin-responsive basal ganglia disease revisited: Clinical, radiologic, and genetic findings","volume":"80","author":"Tabarki","year":"2013","journal-title":"Neurology"},{"key":"R23-12-20240828","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00234-009-0604-x","article-title":"Neuroimaging findings in pediatric Wernicke encephalopathy: A review","volume":"52","author":"Zuccoli","year":"2010","journal-title":"Neuroradiology"},{"key":"R24-12-20240828","doi-asserted-by":"crossref","first-page":"e0149055","DOI":"10.1371\/journal.pone.0149055","article-title":"Novel SLC19A3 promoter deletion and allelic silencing in biotin-thiamine-responsive basal ganglia encephalopathy","volume":"11","author":"Flones","year":"2016","journal-title":"PLoS One"},{"key":"R25-12-20240828","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/aian.AIAN_612_19","article-title":"Movement disorders in inherited metabolic diseases in children","volume":"23","author":"Saini","year":"2020","journal-title":"Ann Indian Acad Neurol"},{"key":"R26-12-20240828","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0037-1607191","article-title":"SLC19A3 gene defects sorting the phenotype and acronyms: Review","volume":"49","author":"Alfadhel","year":"2018","journal-title":"Neuropediatrics"},{"key":"R27-12-20240828","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1021\/acs.molpharmaceut.5b00501","article-title":"Metformin is a substrate and inhibitor of the human thiamine transporter, THTR-2 (SLC19A3)","volume":"12","author":"Liang","year":"2015","journal-title":"Mol Pharm"},{"key":"R28-12-20240828","doi-asserted-by":"crossref","first-page":"2329048X17730742","DOI":"10.1177\/2329048X17730742","article-title":"Psychological assessment of patients with biotin-thiamine-responsive basal ganglia disease","volume":"4","author":"Alfadhel","year":"2017","journal-title":"Child Neurol Open"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.AIAN_952_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:23:49Z","timestamp":1787844229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.AIAN_952_20"}},"subtitle":["A Treatable Neurometabolic Disorder"],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_952_20","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}